Disruption of an SP2/KLF6 repression complex by SHP is required for farnesoid X receptor-induced endothelial cell migration - PubMed (original) (raw)
. 2006 Dec 22;281(51):39105-13.
doi: 10.1074/jbc.M607720200. Epub 2006 Oct 27.
Affiliations
- PMID: 17071613
- DOI: 10.1074/jbc.M607720200
Free article
Disruption of an SP2/KLF6 repression complex by SHP is required for farnesoid X receptor-induced endothelial cell migration
Amitava Das et al. J Biol Chem. 2006.
Free article
Abstract
The farnesoid X receptor (FXR) signaling pathway regulates bile acid and cholesterol homeostasis. Here, we demonstrate, using a variety of gain- and loss-of-function approaches, a role of FXR in the process of cell motility, which involves the small heterodimeric partner (SHP)-dependent up-regulation of matrix metalloproteinase-9. We use this observation to reveal a transcriptional regulatory mechanism involving the SP/KLF transcription factors, SP2 and KLF6. Small interference RNA-based silencing studies in combination with promoter, gel shift, and chromatin immunoprecipitation assays indicate that SP2 and KLF6 bind to the matrix metalloproteinase-9 promoter and together function to maintain this gene in a silenced state. However, upon activation of FXR, SHP interacts with SP2 and KLF6, disrupting the SP2/KLF6 repressor complex. Thus, together, these studies identify a mechanism for antagonizing Sp/KLF protein repression function via SHP, with this process regulating endothelial cell motility.
Publication types
MeSH terms
Substances
Grants and funding
- R01-59388/PHS HHS/United States
- P01 HL055552/HL/NHLBI NIH HHS/United States
- P50 CA102701/CA/NCI NIH HHS/United States
- DK 52913/DK/NIDDK NIH HHS/United States
- P01-HL076540/HL/NHLBI NIH HHS/United States
- R01-59615/PHS HHS/United States
- R01 DK059615/DK/NIDDK NIH HHS/United States
- R01 DK052913/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources